Czechia vs El Salvador: The number of people with susceptibility test result for rifampicin
Czechia
239
in 2021
El Salvador
316
in 2021
Czechia rank
90th
El Salvador rank
87th
The number of people with susceptibility test result for rifampicin over time
- Czechia
- El Salvador
How they compare
El Salvador currently reports 316 against 239 in Czechia, a difference of 77.
That makes El Salvador's figure about 1.3 times Czechia's.
Across all 5 years both countries report, El Salvador has been ahead every year.
Czechia ranks 90th and El Salvador ranks 87th of 155 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 294 | 844.33 | 550.33 | El Salvador |
| 2020s | 231 | 418.5 | 187.5 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or El Salvador?
- El Salvador, at 316 against 239 in Czechia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and El Salvador?
- 77, with El Salvador ahead.
- How many years of comparable data are there for Czechia and El Salvador?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and El Salvador rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 90th and El Salvador ranks 87th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.